#USA #Houston #Protein Synthesis #Sino Biological #XPressMAX

Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit

Sino Biological, Inc., a global leader in recombinant technology, proudly announces the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Catalog # CFKIT02). This cutting-edge solution is specifically designed to enhance high-throughput screening processes powered by artificial intelligence (AI) for antibody-based drug discovery.

A New Era in Protein Synthesis

The XPressMAX™ kit utilizes advanced cell-free protein synthesis technology, enabling the efficient and rapid production of target proteins and antibodies in vitro. By eliminating the limitations associated with traditional cellular expression systems, this kit significantly streamlines research methodologies, allowing scientists to focus on critical tasks that lead to breakthroughs in drug development.

This innovative system is strategically tailored to integrate seamlessly with AI-driven screening platforms, assisting researchers in accelerating the identification and optimization of antibody candidates. As a result, the XPressMAX™ kit reduces both development costs and timelines, promising a more efficient path for medical discovery.

Key Features and Advantages of XPressMAX™

Built on an E. coli lysate framework, the kit comprises all essential components required for transcription and translation, ensuring a smooth synthesis process directly from plasmids or PCR templates. Its design focuses on antibody-driven drug discovery, leading to the rapid expression and validation of VHH, scFv, Fab, and mini proteins. By leveraging XPressMAX™, Sino Biological has constructed a high-performance cell-free platform capable of validating over 2,000 scFv/VHH molecules within a span of just three to four weeks, matching the rapid iteration pacing of AI technologies.

Highlights of XPressMAX™:

• - Ultra-Fast Synthesis: Achieve synthesis completion in as little as 3 hours.
• - High Success Rate: Enjoy a success rate exceeding 99%.
• - Complex Disulfide Linkages: Facilitate the creation of native folded proteins and bioactivity without the need for additional enhancers.

Dr. Rob Burgess, Commercial Director of Sino Biological USA, emphasized the significance of this development, stating, "Our XPressMAX™ represents a significant advancement in research tools and reagents for discovering next-generation therapies. By combining rapid and reliable protein expression capabilities with intelligent screening, we help our partners reduce antibody discovery timelines without compromising quality."

Dr. Jie Zhang, CEO of Sino Biological, shared insights into the revolutionary integration of AI in antibody screening. He remarked, "AI is transforming antibody screening, but it requires expression systems capable of matching its speed and efficacy. XPressMAX™ achieves rapid and successful expression of complex proteins in just 3 hours."

Learn More and Get Started

Researchers interested in the XPressMAX™ Cell-Free Protein Synthesis Kit can explore more details at www.sinobiological.com or can request a free sample by clicking on the designated link on their website. This kit not only enhances laboratory efficiency but is pivotal in accelerating the journey towards groundbreaking medical solutions.

About Sino Biological

Sino Biological sustains a robust reputation as an international provider of reagents and CRO services, focusing on recombinant protein production and antibody development. With its Bioprocessing Center (C4B) located in Houston, USA, alongside SignalChem Biotech in Canada, the company ensures tailored solutions meeting researchers’ diverse needs across the globe. Serving research endeavors in over 90 countries, Sino Biological adheres to a stringent quality management system across its entire product range.

For press inquiries, contact Sino Biological at email protected] or visit [www.sinobiological.com for more news and developments.